Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Bredeson, Christopher  [Clear All Filters]
Journal Article
Cohen, J.A., Baldassari, L.E., Atkins, H.L., Bowen, J.D., Bredeson, C., Carpenter, P.A., Corboy, J.R., Freedman, M.S., Griffith, L.M., Lowsky, R., et al. (2019). AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT-REFRACTORY RELAPSING MULTIPLE SCLEROSIS: POSITION STATEMENT FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION.Biol Blood Marrow Transplant.
Prokopishyn, N.L., Logan, B.R., Kiefer, D.M., Sees, J.A., Chitphakdithai, P., Ahmed, I.A., Anderlini, P.N., Beitinjaneh, A.M., Bredeson, C., Cerny, J., et al. (2019). The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time.Biol Blood Marrow Transplant.
Hamilton, B.K., Liu, Y., Hemmer, M.T., Majhail, N., Ringdén, O., Kim, D., Costa, L., Stuart, R., Alousi, A., Pidala, J.A., et al. (2019). Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant.
Pasquini, M.C., Le-Rademacher, J., Zhu, X., Artz, A., DiPersio, J., Fernandez, H., Mineishi, S., Kamishohara, M., Mehta, J., Nakamura, Y., et al. (2016). Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.Biol Blood Marrow Transplant.
Rosko, A., Wang, H.-L., de Lima, M., Sandmaier, B., H Khoury, J., Artz, A., Brammer, J., Bredeson, C., Farag, S., Kharfan-Dabaja, M., et al. (2016). Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B-cell Acute Lymphoblastic Leukemia.Am J Hematol.